Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

623 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urosepsis--from the view of the urologist.
Wagenlehner FM, Pilatz A, Weidner W. Wagenlehner FM, et al. Among authors: weidner w. Int J Antimicrob Agents. 2011 Dec;38 Suppl:51-7. doi: 10.1016/j.ijantimicag.2011.09.007. Epub 2011 Oct 10. Int J Antimicrob Agents. 2011. PMID: 21993485 Review.
Optimal management of urosepsis from the urological perspective.
Wagenlehner FM, Weidner W, Naber KG. Wagenlehner FM, et al. Among authors: weidner w. Int J Antimicrob Agents. 2007 Nov;30(5):390-7. doi: 10.1016/j.ijantimicag.2007.06.027. Epub 2007 Aug 28. Int J Antimicrob Agents. 2007. PMID: 17728107 Review.
[Rational antibiotic therapy of urinary tract infections].
Wagenlehner FM, Naber KG, Weidner W. Wagenlehner FM, et al. Among authors: weidner w. Med Monatsschr Pharm. 2008 Oct;31(10):385-90; quiz 391-2. Med Monatsschr Pharm. 2008. PMID: 18972869 Review. German.
Emerging drugs for bacterial urinary tract infections.
Wagenlehner FM, Weidner W, Perletti G, Naber KG. Wagenlehner FM, et al. Among authors: weidner w. Expert Opin Emerg Drugs. 2010 Sep;15(3):375-97. doi: 10.1517/14728214.2010.500613. Expert Opin Emerg Drugs. 2010. PMID: 20569081 Review.
Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.
Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Çek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE; GPIU investigators. Wagenlehner FM, et al. Among authors: weidner w. Eur Urol. 2013 Mar;63(3):521-7. doi: 10.1016/j.eururo.2012.06.003. Epub 2012 Jun 12. Eur Urol. 2013. PMID: 22704727
Bacterial prostatitis.
Wagenlehner FM, Pilatz A, Bschleipfer T, Diemer T, Linn T, Meinhardt A, Schagdarsurengin U, Dansranjavin T, Schuppe HC, Weidner W. Wagenlehner FM, et al. Among authors: weidner w. World J Urol. 2013 Aug;31(4):711-6. doi: 10.1007/s00345-013-1055-x. Epub 2013 Mar 22. World J Urol. 2013. PMID: 23519458 Review.
Diagnosis and management for urosepsis.
Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA. Wagenlehner FM, et al. Among authors: weidner w. Int J Urol. 2013 Oct;20(10):963-70. doi: 10.1111/iju.12200. Epub 2013 May 29. Int J Urol. 2013. PMID: 23714209 Review.
Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.
Wagenlehner FM, Münch F, Pilatz A, Bärmann B, Weidner W, Wagenlehner CM, Straubinger M, Blenk H, Pfister W, Kresken M, Naber KG. Wagenlehner FM, et al. Among authors: weidner w. Antimicrob Agents Chemother. 2014;58(2):713-21. doi: 10.1128/AAC.02147-13. Epub 2013 Nov 11. Antimicrob Agents Chemother. 2014. PMID: 24217699 Free PMC article. Clinical Trial.
623 results